This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Selenium supplementation and prostate cancer risk

Authoring team

  • in a study investigating whether selenium and/or vitamin E supplementation (either 200 µg of selenomethionine or 400 IU of synthetic vitamin E, given orally alone or combined for a median of 5.5 years) would prevent prostate cancer the authors concluded that:
    • "...SELECT has definitively demonstrated that selenium, vitamin E, or selenium with vitamin E (at the tested doses and formulations) did not prevent prostate cancer in the generally healthy, heterogeneous population of men in SELECT..."

  • a further study investigated whether vitamin E supplentation or vitamin C supplementation might prevent prostate cancer or reduce total cancer risk
    • in this large, long-term trial of male physicians, neither vitamin E nor C supplementation reduced the risk of prostate or total cancer (2)

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.